EyePoint, Inc (EYPT)vsRevolution Medicines Inc (RVMD)
EYPT
EyePoint, Inc
$4.23
-0.47%
HEALTHCARE · Cap: $374.16M
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
EyePoint, Inc generates 276% more annual revenue ($2.79M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. EYPT earns a higher WallStSmart Score of 35/100 (F).
EYPT
Hold35
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 161.7% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
Trading at 10.6x book value
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : EYPT
The strongest argument for EYPT centers on Revenue Growth, Debt/Equity. Revenue growth of 161.7% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : EYPT
The primary concerns for EYPT are Price/Book, EPS Growth, Market Cap.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
EYPT profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
EYPT carries more volatility with a beta of 1.64 — expect wider price swings.
EYPT is growing revenue faster at 161.7% — sustainability is the question.
EYPT generates stronger free cash flow (-64M), providing more financial flexibility.
Bottom Line
EYPT scores higher overall (35/100 vs 24/100) and 161.7% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
EyePoint, Inc
HEALTHCARE · BIOTECHNOLOGY · USA
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?